3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Neoplasms
5
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Lymphoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Neoplasms, Plasma Cell
2
Lung Neoplasms
2
Hodgkin Disease
2
Glioblastoma
2
Carcinoma, Renal Cell
2
Vulvar Neoplasms
1
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Sarcoma, Kaposi
1
Prostate Cancer Recurrent
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostate Cancer Recurrent
×
Nelfinavir
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled